IPM Magazine

Volume 09, Issue No. 3, June 2022

In this issue we explore how the advent of digital pathology will not only improve efficiencies of scale, save time, reduce workloads, create more precise and accurate diagnoses, but will provide insights that will ultimately pave the way for a deeper pipeline of targeted therapeutic candidates.

Damian Doherty

Editor in Chief

Browse the print magazine as a flipbook

Website Content from This Issue

From Slide to Pixels: How Digital Pathology Promises to Impact the Field of Precision Oncology

cloud computing

How Digital Pathology is Advancing Biomarker Identification & Drug Discovery

Woman side view, memory loss, cognitive decline, forgetting things, degenerative disease. Brain problems. Parkinson and Alzheimer´s desease.

Pathology is Poised for the Digital Revolution

The Evolution of CRISPR Technology from Editing to Diagnostics

Concept of biochemistry with DNA molecule

How Innate Lymphoid Cells Help Keep Us Healthy Against Covid-19

William Haseltine

The Pandemic Supercharged Decentralized Trials, Now What?

Online Medical consultation and treatment, cell phone,

Spatial Transcriptomics Thrives on New Approaches

mouse liver image

Liquid Biopsy: How to Embrace Perfection?

Abstract Molecular structure

Top 5 RNA Therapeutics Companies to Watch in 2022

Coronavirus RNA strand

The Human Genome: Finished in High Fidelity

Genetic engineering concept. DNA. Gene therapy. Medical technology

Asked and Answered: All of Us and What It Means to All of You

Genetic research at the laboratory

Relatively Speaking: How Digital Platforms can Ensure Equitable Access to Groundbreaking Healthcare Technologies

digital heads

Humain Lens: The Disruptive Impact of AI and Precision Lung Data on Respiratory Trials

Digital eye

The Curious Scholars Present: Jackets and Genes

The Curious Scholars Book Cover illustration

Choosing the Right Spatial Technology

SMI Raw Data

The Current State of Companion Diagnostics in Oncology—A Strategy Review

CDx Reimbursement and Funding Challenges and Potential Solutions from the European Perspective

Inside Precision Medicine